liveBook · Manning

Machine learning

As explained in Build AI Drug Discovery Pipelines

Machine learning is a computational approach that learns patterns or predictive functions from data rather than relying solely on explicitly programmed rules.

Machine learning (ML) uses examples to learn patterns or predictive functions from data, rather than relying solely on explicitly programmed rules. In drug discovery, it can help prioritize molecules for testing across a chemical search space too large to explore exhaustively. ML is a subfield of artificial intelligence; deep learning is a subfield of ML that uses deep neural networks. section 1.1.1 section 1.5

A molecule must first be represented in a form a model can use, such as a SMILES string or a molecular graph. In supervised learning, measured properties provide labels: for example, an assay may report whether a compound binds a target or harms cells. The quality and consistency of those measurements limit what the model can learn. section 1.5 section 1.1.1

During training, a model learns a mapping from features—characteristics of each example—to labels. In a parametric model, a learning algorithm adjusts weights using a loss function for individual errors and a cost function that aggregates them. After training, the weights are frozen and the model makes predictions on new inputs during inference. section 3.0 section 3.3.1

Predicting cardiotoxicity

A ligand-based screening project can use molecular features to predict whether compounds block hERG, a property relevant to cardiotoxicity. Gather and standardize molecule data, train a linear classification model, then evaluate its predictions with confusion-matrix metrics. The aim is not just to fit known compounds, but to generalize to compounds the model has not seen. section 3.0 section 3.3.1 section 3.5

Figure 3.9 Parametric ML model during training. Our ML model learns a function that maps each input data instance to a prediction about a property of interest. The loss and optimization functions measure and aggregate the performance of the model’s predictions. In tandem with a learning routine, the model’s weights are updated such that, in the next iteration of training, the model will reduce its previous error and perform better.

Follow how a parametric model turns inputs into predictions and updates its weights using error during training. section 3.3.1

A practical ML workflow includes:

  • Define the problem and success criteria, and decide whether ML is appropriate. section 3.0
  • Acquire, explore, clean and standardize data; convert relevant characteristics into model features. section 3.0 section 3.5
  • Train and compare models, analyze errors, and use cross-validation and regularization to address generalization and overfitting. section 3.0 section 3.5
  • Save the selected model for use on new data; in production, monitor performance and reassess whether it meets its objective. section 3.5 section 3.0

ML is not always the best screening method. Simple compound filters and similarity searches provide alternatives and comparison points. In a hierarchical screening pipeline, inexpensive filters can reduce a large library before more costly methods such as docking. For ligand-based classification, examples of both positive and negative compounds make ML available; with only positive examples, search-based strategies may be more appropriate. section 2.1.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains training through loss, cost and parameter updates, and walks through model development while leaving production deployment and maintenance out of scope.
Examples
Uses cardiotoxicity prediction and hERG blocking to illustrate a ligand-based classification project.
What it assumes
Introduces molecular representations and foundational ML terminology without assuming a single disciplinary background.
What you can do after
Apply it via Scikit-Learn to train and evaluate a linear classifier, tune hyperparameters, and save the model for use on other data.
How it connects
Connects machine learning with molecular representations, deep learning, virtual screening, cross-validation and regularization.

Also explained in

Compare how 49 books explain machine learning →

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.